Newsletter | July 31, 2026

07.31.26 -- Supply Chain Orchestration, Priorities For Smaller CGT Biotechs

FOCUS ON SUPPLY CHAIN

Supply Chain Orchestration, Priorities For Smaller CGT Biotechs

By Cell & Gene Live

This segment of Cell & Gene Live, How CGT Developers Can Choose the Right Manufacturing Model for Their Pipeline, features Omkar Kawalekar, Ph.D., Manufacturing & Supply Chain Lead, Deloitte Consulting and Zoe Zheng, Executive Director, Pipeline Technical and Strategic Lead, Legend Biotech focuses on supply chain orchestration as a control-tower challenge, with the biggest vulnerabilities showing up in patient scheduling, data fragmentation, and QC/release bottlenecks.

PTFE Containment: Viable For Temperature-Sensitive Protection

Article | W.L. Gore & Associates

See why single-use cold-chain containers made with polytetrafluoroethylene fluoropolymers may be less susceptible to failure and breakage at cold temperatures.

FOCUS ON CLINICAL TRIALS

Mergers And Acquisitions: How Institutional Knowledge Protects Value

Article | Veristat, Inc.

M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.

Investigational Insights: Elevating IDS Practice Through Continuing Education

Webinar | McCreadie Group

Discover how leading IDS teams are using automation and standardized digital workflows to streamline protocol management, reduce errors, improve efficiency, and strengthen research operations.

The True ROI Of Decentralized Clinical Trials

White Paper | MRN - Medical Research Network

Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

CLINICAL TRIALS SOLUTIONS

•

Unlocking Healthier Futures With Cell And Gene Therapy - Cencora

Connect With Cell & Gene: